$52.40
1.76% yesterday
NYSE, May 29, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$52.40
+17.36 49.54% 1M
+20.18 62.63% 6M
+28.22 116.71% YTD
+32.82 167.62% 1Y
+48.32 1,184.31% 3Y
+42.47 427.52% 5Y
+42.60 434.69% 10Y
NYSE, Closing price Thu, May 29 2025
-0.94 1.76%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $11.94b
Enterprise Value $11.62b
P/E (TTM) P/E ratio 80.82
EV/FCF (TTM) EV/FCF 49.12
EV/Sales (TTM) EV/Sales 6.51
P/S ratio (TTM) P/S ratio 6.69
P/B ratio (TTM) P/B ratio 21.71
Revenue growth (TTM) Revenue growth 85.99%
Revenue (TTM) Revenue $1.78b
EBIT (operating result TTM) EBIT $115.57m
Free Cash Flow (TTM) Free Cash Flow $236.51m
Cash position $322.67m
EPS (TTM) EPS $0.66
P/E forward 80.79
P/S forward 5.09
EV/Sales forward 4.95
Short interest 34.59%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

6x Buy
38%
8x Hold
50%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
38%
Hold
50%
Sell
13%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,784 1,784
86% 86%
100%
- Direct Costs 410 410
143% 143%
23%
1,375 1,375
74% 74%
77%
- Selling and Administrative Expenses 1,259 1,259
58% 58%
71%
- Research and Development Expense - -
-
-
138 138
2,698% 2,698%
8%
- Depreciation and Amortization 22 22
115% 115%
1%
EBIT (Operating Income) EBIT 116 116
2,214% 2,214%
6%
Net Profit 164 164
7,096% 7,096%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Positive
Seeking Alpha
about 8 hours ago
Hims & Hers Health shows strong growth in subscribers, revenue, and profitability, driven by expanding offerings and strategic partnerships, especially in weight loss and dermatology. HIMS posted stellar Q1 FY 2025: Revenue +110%, EBITDA +181%, EPS +300%. Growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Management's ambitious 2030 strategy leverages AI, new specialti...
Positive
The Motley Fool
2 days ago
This year has had its ups and downs on Wall Street, but some investments are rolling. There are 14 stocks with market caps north of $1 billion that have more than doubled so far in 2025 -- and some of the names will surprise you.
Neutral
Schaeffers Research
2 days ago
Our volatility scorecard has a pretty good feel for the market right now.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today